Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 52 peer-reviewed journal articles Updated
Clinical Immunology · Mendelian Susceptibility to Mycobacterial Diseases

Mendelian Susceptibility to Mycobacterial Diseases (MSMD) due to Partial STAT1 Deficiency: A Patient Guide

At a Glance

Partial STAT1 deficiency causes a rare inherited immune vulnerability mainly to BCG and environmental mycobacteria. Avoid BCG, have live vaccines assessed by an immunologist, and follow an individualized infection plan with immunology and infectious disease specialists.

Mendelian Susceptibility to Mycobacterial Disease (MSMD) due to partial STAT1 deficiency is a rare genetic condition that affects how your immune system communicates when it encounters specific types of invaders. In a healthy system, cells use a protein called interferon-gamma as a critical alarm signal to trigger the destruction of bacteria that hide inside cells. Because of a change in your STAT1 gene, your immune cells are less able to “hear” or respond to this signal, creating a specific vulnerability to a family of germs known as mycobacteria [1][2].

This susceptibility primarily involves mycobacteria, which include the BCG vaccine strain (Bacillus Calmette-Guérin) and environmental mycobacteria found commonly in soil and water. While these germs rarely cause illness in the general population, they can cause persistent infections in the lymph nodes, bones, or skin of individuals with this condition. Depending on the exact genetic variant and residual function, the immune system may also struggle to control certain viruses, particularly those in the herpesvirus family [3][4].

Living with this diagnosis requires a shift toward proactive prevention and highly individualized, specialized care.

  • Vaccines: A critical part of staying healthy is the strict avoidance of live bacterial vaccines, especially the BCG vaccine. If you or your child are accidentally given the BCG vaccine, contact your immunology or infectious disease team urgently—do not wait for symptoms to appear. The safety of live viral vaccines (like MMR or chickenpox) must be evaluated individually by your immunologist based on your genotype. Inactivated vaccines are generally safe, though their effectiveness may vary [5][6].
  • Treatment: Unlike more severe forms of immune deficiency that might require an early bone marrow transplant, management for partial STAT1 deficiency typically focuses on carefully selected antibiotic therapy to treat active infections. This is not a universal prophylactic rule—your specialist will evaluate your history, genotype, and exposure to design a plan that balances infection control against the risks of drug toxicity and resistance [6][7].

Although the diagnosis is lifelong and requires ongoing monitoring by a team of specialists, understanding the specific “blind spot” in your immune system allows for a targeted approach to your health. By working closely with immunologists and infectious disease experts to manage your environment and medications, you can navigate the challenges of MSMD while maintaining a focus on your daily life and long-term well-being [7][8].

In this guide

6 chapters

01

Understanding Your Diagnosis: MSMD due to Partial STAT1 Deficiency

Learn what partial STAT1 deficiency means in MSMD, including genetic forms, infection risks, vaccine safety, prevention, family testing, and questions for care.

02

Watching for Symptoms and Knowing When to Act

Learn which symptoms of partial STAT1 deficiency need prompt care, including swollen nodes, bone pain, severe viral illness, sepsis, and HLH red flags.

03

The Biology of Your Diagnosis and Similar Conditions

Learn how partial STAT1 deficiency affects immune signaling, differs from complete deficiency and STAT1 gain-of-function, and shapes treatment decisions.

04

Medical Testing and Understanding Your Reports

Learn how to read partial STAT1 deficiency reports, including genetic variants, functional assays, mycobacterial identification, and drug susceptibility results.

05

The Standard of Care and Treatment Approaches

Learn how partial STAT1 deficiency is treated, including antibiotics, monitoring, vaccine precautions, interferon-gamma, and when transplant is considered.

06

Building Your Care Team and Daily Life Strategies

Learn how to manage partial STAT1 deficiency through specialist care, medication safety checks, family planning, vaccine safety and infection-risk reduction.

Common questions in this guide

What is MSMD caused by partial STAT1 deficiency?
It is a rare inherited immune condition in which a change in the STAT1 gene makes immune cells less able to respond to interferon-gamma. This mainly increases the risk of persistent infections from BCG and environmental mycobacteria, although some people may also have difficulty controlling certain herpesviruses.
Why must people with partial STAT1 deficiency avoid the BCG vaccine?
BCG is a live bacterial vaccine, and partial STAT1 deficiency can make it harder for the immune system to control the vaccine bacteria. If you or your child receives BCG accidentally, contact your immunology or infectious disease team urgently, even if no symptoms have appeared.
Are other vaccines safe with partial STAT1 deficiency?
Inactivated vaccines are generally considered safe, although they may not work as strongly in every person. Live viral vaccines, such as MMR or chickenpox vaccine, should be considered individually by an immunologist who knows the person’s STAT1 variant.
Which infections are most concerning in MSMD?
The main concern is infection with mycobacteria, including BCG and environmental organisms found in soil and water. Depending on the STAT1 variant and remaining immune function, certain herpesviruses may also cause problems.
How is partial STAT1 deficiency treated?
Treatment usually involves carefully selected antibiotics when an active infection is present. Preventive antibiotics are not automatically appropriate for everyone; a specialist weighs the person’s history, genetic findings, exposures, drug toxicity, and resistance risks.
What should I do if I develop a fever or a rapidly worsening infection?
Ask your care team for a written emergency plan that explains whom to contact and how quickly to seek care. Because infections can become serious, follow that plan promptly rather than waiting for symptoms to improve on their own.
Can partial STAT1 deficiency affect my relatives or future children?
The inheritance pattern depends on the specific STAT1 variant and whether the condition is autosomal dominant or autosomal recessive. A medical genetics professional can explain the implications for siblings and future children and discuss whether family testing is appropriate.

Get notified when new evidence is published on Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Genetic and Functional Identifying of Novel STAT1 Loss-of-Function Mutations in Patients with Diverse Clinical Phenotypes.

    Chen X, Chen J, Chen R, et al.

    Journal of clinical immunology 2022; (42(8)):1778-1794 doi:10.1007/s10875-022-01339-w.

    PMID: 35976469
  2. 2

    A heterozygous dominant-negative mutation in the coiled-coil domain of STAT1 is the cause of autosomal-dominant Mendelian susceptibility to mycobacterial diseases.

    Ueki M, Yamada M, Ito K, et al.

    Clinical immunology (Orlando, Fla.) 2017; (174()):24-31 doi:10.1016/j.clim.2016.11.004.

    PMID: 27856304
  3. 3

    What We Have Here Is a Failure to Communicate: Interleukin-12 / Interferon-gamma Axis Defects and Mendelian Susceptibility to Mycobacterial Disease.

    Johnston AΜ, Rider NL, Freeman AF, et al.

    The journal of allergy and clinical immunology. In practice 2026; (14(7)):1529-1539 doi:10.1016/j.jaip.2026.02.026.

    PMID: 41786143
  4. 4

    Genetic, Immunological, and Clinical Features of 32 Patients with Autosomal Recessive STAT1 Deficiency.

    Le Voyer T, Sakata S, Tsumura M, et al.

    Journal of immunology (Baltimore, Md. : 1950) 2021; (207(1)):133-152 doi:10.4049/jimmunol.2001451.

    PMID: 34183371
  5. 5

    Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds.

    Errami A, Baghdadi JE, Ailal F, et al.

    Journal of clinical immunology 2023; (43(4)):728-740 doi:10.1007/s10875-022-01419-x.

    PMID: 36630059
  6. 6

    Clinical recommendations for diagnosis and management of Mendelian susceptibility to mycobacterial disease in resource-limited settings.

    Cornelissen H, Glanzmann B, van Coller A, et al.

    The journal of allergy and clinical immunology. Global 2025; (4(4)):100540 doi:10.1016/j.jacig.2025.100540.

    PMID: 41048447
  7. 7

    Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review.

    Zhang W, Chen X, Gao G, et al.

    Frontiers in immunology 2021; (12()):654406 doi:10.3389/fimmu.2021.654406.

    PMID: 33777053
  8. 8

    Novel STAT1 Variants in Japanese Patients with Isolated Mendelian Susceptibility to Mycobacterial Diseases.

    Ono R, Tsumura M, Shima S, et al.

    Journal of clinical immunology 2023; (43(2)):466-478 doi:10.1007/s10875-022-01396-1.

    PMID: 36336768

This page is for informational purposes only and does not constitute medical advice. Your immunologist and infectious disease specialist should guide vaccine decisions, emergency plans, and treatment for partial STAT1 deficiency.